How I Invest
I have a diversified portfolio of low cost index ETFs that make up approximately 50% of my portfolio, and invest the other 50% in individual companies based on momentum, catalysts or valuation. A significant portion of my portfolio is in biotech and pharma, and many of my positions are initiated based solely on a capturing return generated by a catalyst or event, generally from data on clinical trials or FDA approval decisions. I often use options in these situations. I prefer to hold stocks for a longer term but won't hesitate to trade in and out of positions and take profits or realize losses quickly.